Sökning: onr:"swepub:oai:DiVA.org:oru-70945" > Link between plasma...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05325naa a2200493 4500 | |
001 | oai:DiVA.org:oru-70945 | |
003 | SwePub | |
008 | 190826s2009 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-709452 URI |
024 | 7 | a https://doi.org/10.1007/s00125-009-1482-92 DOI |
040 | a (SwePub)oru | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a de Mello, V. D. F.u Department of Clinical Nutrition/Food and Health Research Centre, School of Public Health and Clinical Nutrition, University of Kuopio, Kuopio, Finland4 aut |
245 | 1 0 | a Link between plasma ceramides, inflammation and insulin resistance :b association with serum IL-6 concentration in patients with coronary heart disease |
264 | c 2009-08-11 | |
264 | 1 | b Springer,c 2009 |
338 | a print2 rdacarrier | |
520 | a AIMS/HYPOTHESIS: Ceramides and IL-6 have a role in immune-inflammatory responses and cardiovascular diseases, and are suggested to be involved in insulin and glucose metabolism. We sought to assess the associations of circulating levels of IL-6, TNF-alpha and high-sensitivity C reactive protein (hsCRP), which are inflammatory markers related to insulin resistance (IR), with the plasma lipid metabolites ceramides and diacylglycerols (DAG) in patients with CHD.METHODS: Cross-sectional analyses were carried out on data from 33 patients with CHD. Serum levels of the inflammatory markers and plasma lipid metabolites (lipidomics approach performed by ultra-performance liquid chromatography coupled to electrospray ionisation MS) were measured at the same time point as insulin resistance (IR) (HOMA-IR index).RESULTS: Serum circulating levels of IL-6 were strongly correlated with plasma ceramide concentrations (r = 0.59, p < 0.001). Adjustments for serum TNF-alpha or hsCRP levels, smoking, BMI, age, sex or HOMA-IR did not change the results (p < 0.001). After adjustments for the effect of serum inflammatory markers (TNF-alpha or hsCRP), HOMA-IR and BMI the correlation between plasma DAG and serum IL-6 (r = 0.33) was also significant (p < 0.03). In a linear regression model, circulating levels of both ceramides and TNF-alpha had a significant independent influence on circulating levels of IL-6, altogether accounting for 41% of its variation (p < 0.001).CONCLUSIONS/INTERPRETATION: Our results strongly suggest that the link between ceramides, IR and inflammation is related to the inflammatory marker IL-6. Ceramides may contribute to the induction of inflammation involved in IR states that frequently coexist with CHD. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Fysiologi0 (SwePub)301062 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Physiology0 (SwePub)301062 hsv//eng |
653 | a Cardiovascular disease | |
653 | a Ceramides | |
653 | a Diacylglycerols | |
653 | a IL-6 | |
653 | a Inflammation | |
653 | a Insulin resistance | |
653 | a Lipidomics | |
700 | 1 | a Lankinen, M.u Department of Clinical Nutrition/Food and Health Research Centre, School of Public Health and Clinical Nutrition, University of Kuopio, Kuopio, Finland; VTT Technical Research Centre of Finland, Espoo, Finland4 aut |
700 | 1 | a Schwab, U.u Department of Clinical Nutrition/Food and Health Research Centre, School of Public Health and Clinical Nutrition, University of Kuopio, Kuopio, Finland; Department of Internal Medicine, Kuopio University Hospital, Kuopio, Finland4 aut |
700 | 1 | a Kolehmainen, M.u Department of Clinical Nutrition/Food and Health Research Centre, School of Public Health and Clinical Nutrition, University of Kuopio, Kuopio, Finland4 aut |
700 | 1 | a Lehto, S.u Department of Internal Medicine, Kuopio University Hospital, Kuopio, Finland4 aut |
700 | 1 | a Seppänen-Laakso, T.u VTT Technical Research Centre of Finland, Espoo, Finland4 aut |
700 | 1 | a Oresic, Matej,d 1967-u VTT Technical Research Centre of Finland, Espoo, Finland4 aut0 (Swepub:oru)moc |
700 | 1 | a Pulkkinen, L.u Department of Clinical Nutrition/Food and Health Research Centre, School of Public Health and Clinical Nutrition, University of Kuopio, Kuopio, Finland4 aut |
700 | 1 | a Uusitupa, Mu Department of Clinical Nutrition/Food and Health Research Centre, School of Public Health and Clinical Nutrition, University of Kuopio, Kuopio, Finland4 aut |
700 | 1 | a Erkkilä, A. T.u Department of Public Health, School of Public Health and Clinical Nutrition, University of Kuopio, Kuopio, Finland4 aut |
710 | 2 | a Department of Clinical Nutrition/Food and Health Research Centre, School of Public Health and Clinical Nutrition, University of Kuopio, Kuopio, Finlandb Department of Clinical Nutrition/Food and Health Research Centre, School of Public Health and Clinical Nutrition, University of Kuopio, Kuopio, Finland; VTT Technical Research Centre of Finland, Espoo, Finland4 org |
773 | 0 | t Diabetologiad : Springerg 52:12, s. 2612-2615q 52:12<2612-2615x 0012-186Xx 1432-0428 |
856 | 4 | u https://link.springer.com/content/pdf/10.1007%2Fs00125-009-1482-9.pdf |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-70945 |
856 | 4 8 | u https://doi.org/10.1007/s00125-009-1482-9 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy